Intimation for filing of the application for reclassification of shareholders from Promoter Group to Public Category

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.2%1-day move

₹76.39

prior close

₹76.90

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0-0.6-0.3+0.2+0.2+0.1+0.7-1.3+0.1-1.2+4.4+4.9+6.7—

Up moveDown movePending

AI summary

Anuh Pharma Limited has filed an application with BSE and NSE on May 25, 2026, seeking reclassification of 9 persons from the 'Promoter Group' to the 'Public' category under SEBI LODR Regulation 31A(8)(c). The individuals being reclassified collectively hold 949,988 equity shares representing 0.95% of the company's shareholding. The largest stakeholder among them is Kinjal Siddharth Jhaveri with 816,160 shares (0.81%), while the remaining 8 persons hold less than 0.10% each. This follows an earlier intimation dated May 20, 2026, indicating the process was already in motion.

Likely market impact

This reclassification reduces the Promoter Group's collective shareholding by nearly 1%, which could lower the overall promoter holding percentage. For shareholders, this signals a potential shift in control dynamics and may indicate reduced affiliation of these persons with the company's management.